ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
This site is part of the Siconnects Division of Sciinov Group
This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
Mar 5 , 2025
Epoch Biodesign Secures £18.3M to Scale Enzyme-Driven Plastic Recycling
Plastic recycling is failing only 9% of plastics are recycled globally, while the rest contribute to rising greenhouse gas emissions. Traditional methods struggle with mixed plastics, degrade polymer quality, or demand high energy inputs. Epoch Biodesign aims to change this with enzyme-powered biorecycling, fully recovering materials and producing high value chemicals at cost parity with fossil-based alternatives.
The London based company just raised £18.3M in an oversubscribed Series A round led by Extantia Capital, alongside Inditex, Lowercarbon Capital, Happiness Capital, and others, plus a $1M UK government grant. This brings Epoch’s total funding to £34M.
Founded in 2019 by Jacob Nathan (CEO) and Douglas Kell (CSO), Epoch Biodesign develops AI-designed enzymes to break down plastic at room temperature. Their process enables circular recycling, tackling previously unrecyclable plastics and mixed waste streams. The funding will support their first plant, expand their enzyme library, and drive adoption across industries like fashion, automotive, and chemicals.
With over 40 partnerships and an ambitious goal to process tens of thousands of tonnes of waste by 2028, Epoch Biodesign is redefining plastic recycling proving that waste isn’t just a problem, but an untapped resource.